Kymera Therapeutics, Inc. (KYMR) Up 28% in 3M, Analysts See Further Upside

Kymera Therapeutics, Inc. (NASDAQ:KYMR) is among the 14 champion booming stocks to bargain close now. Its shares person gained implicit 28% successful the past 3 months, with Wall Street anticipating a further uptick of astir 60%, arsenic of the adjacent of concern connected January 12.

However, connected January 6, Wolfe Research downgraded the banal to Peer Perform from Outperform, and according to a study connected TipRanks, the steadfast besides removed its $92 terms people for the company’s shares.

In a probe enactment to investors, Wolfe Research described the banal arsenic ‘a mediocre concern successful 2026’, citing a deficiency of catalysts that could thrust an upside and valuation concerns astir the banal among investors. However, the firm’s expert inactive considers Kymera Therapeutics, Inc. (NASDAQ:KYMR) a bully concern implicit the agelong term.

On the aforesaid day, BTIG reiterated its Buy standing connected the banal with a stock terms people of $138. Earlier connected January 5, Citigroup besides kept its Buy standing and maintained an earlier terms people of $110 connected its shares.

In December, the institution announced that it had received Fast Track designation from the FDA for its KT-621 oral STAT6 degrader to dainty atopic dermatitis. This followed promising results from the BroADen Phase 1b objective proceedings that demonstrated the imaginable of treating assorted Type 2 inflammatory diseases crossed metrics done a once-daily intake.

Kymera Therapeutics, Inc. (NASDAQ:KYMR) is simply a biopharmaceutical institution processing macromolecule degradation therapies to code captious aesculapian problems.

While we admit the imaginable of KYMR arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 14 Best S&P 500 Stocks to Buy Now and 11 Most Oversold S&P 500 Stocks Heading into 2026

Disclosure: None.